COVID-19 and Liver Disease: An Evolving Landscape
Seminars in Liver Disease · 01.08.2023 · 43 (03) · 351-366
DOI: 10.1055/a-2157-3318 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.08.2023. Verfasst von Kai Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, COVID-19, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 147 Literaturangaben.
Abstract (Originalsprache)
The COVID-19 pandemic has resulted in significant worldwide morbidity and mortality. In this review, we examine the intricate relationships between COVID-19 and liver diseases. While respiratory manifestations of COVID-19 are well known, its impact and consequences in patients with liver diseases remain an area of ongoing investigation. COVID-19 can induce liver injury through various mechanisms and is associated with higher mortality in individuals with preexisting chronic liver disease. Mortality increases with the severity of chronic liver disease and the level of care required. The outcomes in patients with autoimmune hepatitis remain unclear, whereas liver transplant recipients are more likely to experience symptomatic COVID-19 but have comparable outcomes to the general population. Despite suboptimal immunological response, COVID-19 vaccinations are safe and effective in liver disease, although cases of autoimmune hepatitis-like syndrome have been reported. In conclusion, COVID-19 has significant implications in liver diseases; early recognition and treatments are important for improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada.
- BC Liver Transplant Program, Vancouver, British Columbia, Canada.
- Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Zitieren
APA
Zhu, K., Tsai, O., Chahal, D., Hussaini, T., & Yoshida, E. M. (2023). COVID-19 and Liver Disease: An Evolving Landscape. Seminars in Liver Disease, 43(03), 351-366. https://doi.org/10.1055/a-2157-3318
Vancouver
Zhu K, Tsai O, Chahal D, Hussaini T, Yoshida EM. COVID-19 and Liver Disease: An Evolving Landscape. Seminars in Liver Disease. 2023;43(03):351-366. doi:10.1055/a-2157-3318
BibTeX
@article{Zhu2023,
author = {Zhu, Kai and Tsai, Olivia and Chahal, Daljeet and Hussaini, Trana and Yoshida, Eric M},
title = {COVID-19 and Liver Disease: An Evolving Landscape},
journal = {Seminars in Liver Disease},
year = {2023},
volume = {43},
number = {03},
pages = {351--366},
doi = {10.1055/a-2157-3318}
}
EUVIMED